Lasca Laboratories

Lasca Supports the Campaign Promoted by PRONASIDA

Last Friday, July 26, Laboratorios Lasca participated in the launch of the campaign "Elimination of Mother-to-Child Transmission of HIV, Congenital Syphilis, Hepatitis B, and Chagas (ETMI Plus)," promoted by PRONASIDA, an organization under the Ministry of Public Health and Social Welfare.

The proposed action plan aims to encourage women of childbearing age and pregnant women, as well as their sexual partners, to undergo tests for HIV, syphilis, Hepatitis B, and Chagas. This measure aims to reduce the spread of these diseases and ensure the birth of healthy children, thereby protecting their childhood.

As a leader in the pharmaceutical industry, Lasca supports the project that offers educational actions in prevention, early diagnosis, comprehensive treatment, and epidemiological control, as well as support for pregnant women. The company backs this initiative with the drug Acticilline Penicillin 2,400,000 U.I. and 1,200,000 U.I., Effective in the treatment of infections sensitive to penicillin, including syphilis.

The president of the Paraguayan Federation of Gynecology and Obstetrics highlighted the collaborative effort between scientific societies and the various departments of the Ministry of Health